XWELL (FRA:V9G0) ROCE % : -31.94% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is XWELL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. XWELL's annualized ROCE % for the quarter that ended in Mar. 2024 was -31.94%.

XWELL ROCE % Historical Data

The historical data trend for XWELL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XWELL ROCE % Chart

XWELL Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-136.18

-47.89

5.18

-30.65

-42.46

XWELL Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-40.73	-37.09	-35.44	-55.32	-31.94

XWELL ROCE % Calculation

XWELL's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17.694	/	( ( (66.482 - 10.342)	+	(35.757 - 8.556) )	/ 2 )
	=	-17.694	/	( (56.14	+	27.201)	/ 2 )
	=	-17.694	/	41.6705
	=	-42.46 %

XWELL's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-8.5	/	( ( (35.757 - 8.556)	+	(34.479 - 8.452) )	/ 2 )
	=	-8.5	/	( ( 27.201	+	26.027 )	/ 2 )
	=	-8.5	/	26.614
	=	-31.94 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

XWELL (FRA:V9G0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

XWELL ROCE % Related Terms

Thank you for viewing the detailed overview of XWELL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (FRA:V9G0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (FRA:V9G0) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

XWEL:USA

Address

254 West 31st Street, 11th Floor, New York, NY, USA, 10001

Website

https://www.xwell.com

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

XWELL (FRA:V9G0) Headlines

No Headlines